Relative risk reduction: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett (Started See also) |
||
Line 25: | Line 25: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
==See also== | |||
* [[Randomized controlled trial]] | |||
* [[Absolute risk reduction]] | |||
* [[Number needed to treat]] |
Revision as of 08:12, 12 March 2008
In clinical epidemiology and evidence-based medicine, the relative risk reduction is a measure of the likelihood of a clinical outcome in group of patients exposed to a factor compared to a control group of patients.[1] This measure should be contrasted with the absolute risk reduction.
Calculations
Outcome | ||||
---|---|---|---|---|
Present | Absent | |||
Experimental group | Cell A | Cell B | Total in the experimental group | |
Control group | Cell C | Cell D | Total in the control group | |
Total with the outcome | Total without the outcome |
References
- ↑ Barratt A, Wyer PC, Hatala R, et al (2004). "Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat". CMAJ 171 (4): 353–8. DOI:10.1503/cmaj.1021197. PMID 15313996. Research Blogging.